• CHA Biotech Launches Global CDMO Biz contractpharma
    December 17, 2020
    ​South Korea-based CHA Biotech has launched Matica Biotechnology, a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies.
PharmaSources Customer Service